Summary
Mayo Foundation for Medical Education and Research (Mayo) is a non-profit organization that provides healthcare for complex conditions through its Mayo Clinics. Mayo operates a network of hospitals, clinics and health care facilities, serving communities in Minnesota, Iowa, Georgia and Wisconsin. It also conducts research and trainings for physicians, nurses, and other health professionals. Its services include heart care, transplantation, cancer treatment, neurosciences and medical research. The foundation provides its products and services to consumer, business and professionals. Mayo's research clinics include Cancer Center, Center for Translational Science Activities (CTSA), Institutional Review Board, Clinical Trials and Research Fellow’s Association. Mayo is headquartered in Rochester Minnesota, the US.
Mayo Foundation for Medical Education and Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Qrativ Raises USD8.3 Million in Series A Financing 14
Evelo Biosciences Raises USD50 Million in Series B Financing 15
DayTwo Secures USD12 Million in Series A Funding 16
DayTwo Raises USD12 Million in Series A Financing 17
Second Genome Raises USD42.6 Million in Series B Financing 18
Unity Biotechnology Raises Funds in Venture Financing 20
AssureRx Health Raises Additional USD15 Million in Series D Financing 21
OxThera Raises US$10.7 Million In Venture Financing 22
Partnerships 23
Mayo Clinic and nference Form Joint Venture 23
Baxter International and Mayo Clinic Enter into Research Agreement 24
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 25
EnBiotix Partners with Mayo Clinic 26
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 27
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 28
GE Ventures Forms Joint Venture with Mayo Clinic 29
Morphotek Enters into Agreement with Mayo Clinic 30
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 31
Seres Health Enters into Research Agreement with Mayo Clinic 32
Licensing Agreements 33
Mayo Clinic Enters into Licensing Agreement with ID Pharma 33
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 34
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 35
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 36
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 37
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 38
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 39
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 40
Acquisition 41
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 41
Mayo Foundation for Medical Education and Research - Key Competitors 42
Mayo Foundation for Medical Education and Research - Key Employees 43
Mayo Foundation for Medical Education and Research - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 45
Recent Developments 46
Government and Public Interest 46
Feb 11, 2016: Long-term benefits of 'senolytic' drugs on vascular health in mice 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List Of Tables
List of Tables
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Key Facts 2
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Qrativ Raises USD8.3 Million in Series A Financing 14
Evelo Biosciences Raises USD50 Million in Series B Financing 15
DayTwo Secures USD12 Million in Series A Funding 16
DayTwo Raises USD12 Million in Series A Financing 17
Second Genome Raises USD42.6 Million in Series B Financing 18
Unity Biotechnology Raises Funds in Venture Financing 20
AssureRx Health Raises Additional USD15 Million in Series D Financing 21
OxThera Raises US$10.7 Million In Venture Financing 22
Mayo Clinic and nference Form Joint Venture 23
Baxter International and Mayo Clinic Enter into Research Agreement 24
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 25
EnBiotix Partners with Mayo Clinic 26
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 27
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 28
GE Ventures Forms Joint Venture with Mayo Clinic 29
Morphotek Enters into Agreement with Mayo Clinic 30
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 31
Seres Health Enters into Research Agreement with Mayo Clinic 32
Mayo Clinic Enters into Licensing Agreement with ID Pharma 33
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 34
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 35
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 36
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 37
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 38
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 39
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 40
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 41
Mayo Foundation for Medical Education and Research, Key Competitors 42
Mayo Foundation for Medical Education and Research, Key Employees 43
Mayo Foundation for Medical Education and Research, Subsidiaries 44
Mayo Foundation for Medical Education and Research, Joint Venture 45
List Of Figures
List of Figures
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10
